CytoDyn has an EPS of $-0.1. In 2022, the company made an earnings per share (EPS) of $-0.31. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.1 | -67.74% |
2022 | -$0.31 | 3.33% |
2021 | -$0.3 | -9.09% |
2020 | -$0.33 | - |